PRELIMINARY-REPORT OF A PHASE-I TRIAL OF 90-Y LABELED MONOCLONAL-ANTIBODY (MCAB) B72.3 (CYT 103-90Y) ADMINISTERED WITH CONCURRENT ADMINISTRATION OF EDTA IN REFRACTORY ADENOCARCINOMAS
D. Haller et al., PRELIMINARY-REPORT OF A PHASE-I TRIAL OF 90-Y LABELED MONOCLONAL-ANTIBODY (MCAB) B72.3 (CYT 103-90Y) ADMINISTERED WITH CONCURRENT ADMINISTRATION OF EDTA IN REFRACTORY ADENOCARCINOMAS, The Journal of nuclear medicine, 35(5), 1994, pp. 160000102-160000102